Please login to the form below

Not currently logged in
Email:
Password:

Rapivab

This page shows the latest Rapivab news and features for those working in and with pharma, biotech and healthcare.

BioCryst gets FDA nod for first intravenous flu drug

BioCryst gets FDA nod for first intravenous flu drug

The FDA gave the go-ahead yesterday for Rapivab (peramivir) to treat flu in adults who have been symptomatic for no more than two days, suggesting that regulatory compliance issues at ... Edward Cox, director of the Office of Antimicrobial Products at

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals in June 2015 Pharma deals in June 2015

    85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics